Understandings of the component causes of harm from cigarette smoking in Australia.
harm reduction
nicotine
risk perception
smoking
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
17
03
2019
revised:
19
08
2019
accepted:
26
08
2019
pubmed:
7
11
2019
medline:
15
4
2020
entrez:
7
11
2019
Statut:
ppublish
Résumé
To investigate relationships between smoking-related behaviours and knowledge of the disease risks of smoking and the causes of smoking harms, using a four-way division of 'component causes': nicotine, other substances found in unburned tobacco, combustion products of tobacco and additives. The data were collected using an on-line survey in Australia with 1047 participants in three groups; young non-smokers (18 to 25), young smokers (18 to 25) and older smokers (26 and above). Most participants agreed that cancer and heart disease are major risks of smoking but only a quarter accurately quantified the mortality risk of lifetime daily smoking. Very few (two of 1047) correctly estimated the relative contributions of all four component causes. Post-hoc analyses reinterpreting responses as expressions of relative concern about combustion products and nicotine showed that 29% of participants rated combustion products above nicotine. We delineated six relative concern segments, most of which had distinctive patterns of beliefs and actions. However, higher levels of concern about combustion products were only weakly positively associated with harm reducing beliefs and actions. Most smokers do not appear to understand the risks of smoking and their causes well enough to be able to think systematically about the courses of action open to them to reduce their health risk. To facilitate informed decision-making, tobacco control communicators may need to better balance the dual aims of creating fear/negative affect about smoking and imparting knowledge about the health harms and their mechanisms.
Substances chimiques
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
807-817Subventions
Organisme : NCI NIH HHS
ID : P30 CA138313
Pays : United States
Informations de copyright
© 2019 Australasian Professional Society on Alcohol and other Drugs.
Références
Chapman S, Liberman J. Ensuring smokers are adequately informed: reflections on consumer rights, manufacturer responsibilities, and policy implications. Tob Control 2005;14:iii8-13.
Hoek J. Informed choice and the nanny state: learning from the tobacco industry. Public Health 2015;29:1038-45.
Hammond D, Fong GT, McNeill A, Borland R, Cummings KM. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the international tobacco control (ITC) four country survey. Tob Control 2006;15:iii19-25.
Borland R. What do people's estimates of smoking risk mean? Psychol Health 1997;12:513-31.
Oakes W, Chapman S, Borland R, Balmford J, Trotter L. "Bulletproof sceptics in life's jungle": which self-excepting beliefs about smoking most predict lack of progression toward quitting. Prev Med 2004;39:776-82.
Brewer NT, Morgan JC, Baig SA et al. Public understanding of cigarette smoke constituents: three US surveys. Tob Control 2017;26:592-9.
Bernat J, Ferrer RA, Margolis KA, Blake KD. US adult tobacco users' absolute harm perceptions of traditional and alternative products, information-seeking behaviors, and (mis)beliefs about chemicals in tobacco products. Addict Behav 2017;71:38-45.
Pepper J, Byron MJ, Ribisl KM, Brewer NT. How hearing about harmful chemicals affects smokers' interest in dual use of cigarettes and e-cigarettes. Prev Med 2017;96:144-8.
Morgan JC, Byron MJ, Baig SA, Stepanov I, Brewer NT. How people think about chemicals in cigarette smoke: a systematic review. J Behav Med 2017;40:553-464.
Moracco KE, Morgan JC, Mendel J et al. "My first thought was croutons": perceptions of cigarettes and cigarette smoke constituents among adult smokers and nonsmokers. Nicotine Tob Res 2016;18:1566-74.
Borland R, Cooper J, McNeill A, O'Connor R, Cummings KM. Trends in beliefs about the harmfulness and use of stop-smoking medications and smokeless tobacco products among cigarettes smokers: findings from the ITC four-country survey. Harm Reduct J 2011;8:21.
Czoli C, Fong GT, Mays D, Hammond D. How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therpay and combustible cigarettes. Tob Control 2016;26:e49-58.
Fischoff B. The sciences of science communication. Proc Natl Acad Sci USA 2013;110:14033-9.
Fischoff B. Risk perception and communication. In: Detels R, Gulliford M, Abdool Karim Q, eds. Oxford textbook of global public health. Oxford: Oxford University Press, 2015.
Bruine de Bruin W, Bostrom A. Assessing what to address in science communication. Proc Natl Acad Sci USA 2013;110:14062-8.
Breakwell GM. The psychology of risk. Cambridge: Cambridge University of Press, 2010.
Bloom BS, Engelhart MD, Furst EJ, Hill WH, Krathwohl DR. Taxonomy of educational objectives: the classification of eductional goals. Handbook I. New York: David McKay Company, 1956.
Fowles J, Dybing E. Application of toxicological risk assessment principles to the chemical contituents of cigarette smoke. Tob Control 2003;12:424-30.
Hoffman I, Hoffmann D. The changing cigarette: chemical studies and bioassays. In: Boyle P, Gray N, Henningfield J, Seffrin J, Zatonski W, eds. Tobacco: science, policy and public health. Oxford: Oxford University Press, 2010.
Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smokeless tobacco and cancer. Lancet Oncol 2008;9:667-75.
Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349-59.
Health Do. Australian cigarette ingredient information. 2018. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/health-pubhlth-strateg-drugs-tobacco-ingredients.htm (accessed 25 October 2018)
Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: implications for electronic cigarette use. Trends Cardiovasc Med 2016;26:515-23.
Benowitz NL. Nicotine addiction. N Engl J Med 2010;362:2295-303.
Shiffman S, Ferguson SG, Rohay JM, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction 2008;103:1371-8.
King B, Ndoen E, Borland R. Smokers' risk perceptions and misperceptions of cigarettes, e-cigarettes and nicotine replacement therapies. Drug Alcohol Rev 2018;37:810.
Slovic P, Finucane ML, Peters E, MacGregor DG. The affect heuristic. Eur J Oper Res 2007;177:1333-52.
Slovic P, Peters E. Risk perception and affect. Curr Dir Psychol Sci 2006;15:322-5.
Borland R. CEOS theory: a comprehensive approach to understanding hard to maintain behaviour change. Appl Psychol Health Well Being 2016;9:3-35.
Borland R. Understanding hard to maintain behaviour change: a dual-process approach. Oxford: Wiley-Blackwell, Addiction Press, 2014.
Banks E, Joshy G, Weber MF et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med 2015;13:38.
Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking in developed countries, 1950-2010. Oxford: Clinical Trial Service Unit and Epidemiological Studies Unit, 2012.
Cameron L, Chan CKY. Designing health communications: harnessing the power of affect, imagery, and self-regulation. Soc Personal Psychol Compass 2008;2:262-82.